← Leaderboards
Selina M Luger
University Of Pennsylvania
$1,582,853
Attributed
$1,582,853
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $376.5K · FY2011–13$500K$375K$250K$125K$0
'11
'12
'13
Funding mix
By agency
NIH$1,582,853 · 3
By mechanism
U10$1,086,269 · 1
M01$496,584 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Constantinos Koumenis$17,144,115
- Robert H Vonderheide$28,425,019
- Stephen G Emerson$28,932,839
- Katherine L Nathanson$24,205,332
- Xiaowei Xu$9,845,570
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchNeoplasm /Cancer GeneticsAntisense Nucleic AcidHuman Therapy EvaluationBone Marrow PurgingBiotherapeutic AgentChronic Myelogenous LeukemiaClinical Trial Phase IProtooncogeneAutologous TransplantationAntineoplasticsThiophosphateBone Marrow TransplantationNeoplasm /Cancer TherapyNeoplasm /Cancer ChemotherapyOligonucleotidesGene TherapyCancer TherapyCancer Research Center DirectorCancer FamilyComprehensive Cancer CenterCancer CenterArea
Grant awards (15)
EASTERN COOPERATIVE ONCOLOGY GROUP$333,233
U10 · FY2013 · CA · contact PI
EASTERN COOPERATIVE ONCOLOGY GROUP$376,493
U10 · FY2012 · CA · contact PI
EASTERN COOPERATIVE ONCOLOGY GROUP$376,543
U10 · FY2011 · CA · contact PI
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE$124,146
M01 · FY2002 · RR
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS$124,146
M01 · FY2002 · RR
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE$124,146
M01 · FY2001 · RR
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS$124,146
M01 · FY2001 · RR
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS$0
M01 · FY2001 · RR
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE$0
M01 · FY2001 · RR
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS$0
M01 · FY2000 · RR
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE$0
M01 · FY2000 · RR
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE$0
M01 · FY2000 · RR
AUTOLOGOUS BONE MARROW TRANSPLANTATION: C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE$0
M01 · FY2000 · RR
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS$0
M01 · FY2000 · RR
C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS$0
M01 · FY2000 · RR